Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Immunoproteomically identified GBAA_0345, alkyl hydroperoxide reductase subunit C is a potential target for multivalent anthrax vaccine.

Kim YH, Kim KA, Kim YR, Choi MK, Kim HK, Choi KJ, Chun JH, Cha K, Hong KJ, Lee NG, Yoo CK, Oh HB, Kim TS, Rhie GE.

Proteomics. 2014 Jan;14(1):93-104. doi: 10.1002/pmic.201200495.

PMID:
24273028
2.

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.

Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR Jr.

Infect Immun. 2007 Aug;75(8):4020-9. Epub 2007 May 14.

3.

Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.

Lee DY, Chun JH, Ha HJ, Park J, Kim BS, Oh HB, Rhie GE.

FEMS Immunol Med Microbiol. 2009 Nov;57(2):165-72. doi: 10.1111/j.1574-695X.2009.00595.x. Epub 2009 Aug 6.

4.

Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.

Skoble J, Beaber JW, Gao Y, Lovchik JA, Sower LE, Liu W, Luckett W, Peterson JW, Calendar R, Portnoy DA, Lyons CR, Dubensky TW Jr.

Infect Immun. 2009 Apr;77(4):1649-63. doi: 10.1128/IAI.00530-08. Epub 2009 Jan 21.

5.

Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.

Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR.

Infect Immun. 2009 Mar;77(3):1197-207. doi: 10.1128/IAI.01217-08. Epub 2008 Dec 29.

6.

Identification of the immunogenic spore and vegetative proteins of Bacillus anthracis vaccine strain A16R.

Liu X, Wang D, Ren J, Tong C, Feng E, Wang X, Zhu L, Wang H.

PLoS One. 2013;8(3):e57959. doi: 10.1371/journal.pone.0057959. Epub 2013 Mar 13.

7.

Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.

Yin Y, Zhang J, Dong D, Liu S, Guo Q, Song X, Li G, Fu L, Xu J, Chen W.

Vaccine. 2008 Oct 29;26(46):5814-21. doi: 10.1016/j.vaccine.2008.08.031. Epub 2008 Sep 9.

PMID:
18786589
8.

Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin.

Fellows PF, Linscott MK, Ivins BE, Pitt ML, Rossi CA, Gibbs PH, Friedlander AM.

Vaccine. 2001 Apr 30;19(23-24):3241-7. Erratum in: Vaccine 2001 Nov 12;20(3-4):635.

PMID:
11312020
9.

Anthrax spores make an essential contribution to vaccine efficacy.

Brossier F, Levy M, Mock M.

Infect Immun. 2002 Feb;70(2):661-4.

10.

Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.

Huang J, Mikszta JA, Ferriter MS, Jiang G, Harvey NG, Dyas B, Roy CJ, Ulrich RG, Sullivan VJ.

Hum Vaccin. 2007 May-Jun;3(3):90-3. Epub 2007 May 13.

PMID:
17375001
11.

A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.

Oscherwitz J, Yu F, Cease KB.

J Immunol. 2010 Sep 15;185(6):3661-8. doi: 10.4049/jimmunol.1001749. Epub 2010 Aug 9.

12.

Progress and novel strategies in vaccine development and treatment of anthrax.

Chitlaru T, Altboum Z, Reuveny S, Shafferman A.

Immunol Rev. 2011 Jan;239(1):221-36. doi: 10.1111/j.1600-065X.2010.00969.x. Review.

PMID:
21198675
13.
14.

[Role of the components of the S-layer in immunogenicity of Bacillus anthracis].

Mikshis NI, Korsakova AIu, Bolotnikova MF, Novikova LV, Popov IuA.

Zh Mikrobiol Epidemiol Immunobiol. 2006 Jan-Feb;(1):29-32. Russian.

PMID:
16532637
15.

Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.

Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino S.

Microbiology. 2006 Oct;152(Pt 10):3103-10.

PMID:
17005989
17.

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.

Little SF, Ivins BE, Fellows PF, Pitt ML, Norris SL, Andrews GP.

Vaccine. 2004 Jan 2;22(3-4):422-30.

PMID:
14670324
18.

Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.

Stokes MG, Titball RW, Neeson BN, Galen JE, Walker NJ, Stagg AJ, Jenner DC, Thwaite JE, Nataro JP, Baillie LW, Atkins HS.

Infect Immun. 2007 Apr;75(4):1827-34. Epub 2006 Dec 4.

19.

Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax.

Cohen S, Mendelson I, Altboum Z, Kobiler D, Elhanany E, Bino T, Leitner M, Inbar I, Rosenberg H, Gozes Y, Barak R, Fisher M, Kronman C, Velan B, Shafferman A.

Infect Immun. 2000 Aug;68(8):4549-58.

20.

Immunogenicity of a subunit vaccine against Bacillus anthracis.

Chichester JA, Musiychuk K, de la Rosa P, Horsey A, Stevenson N, Ugulava N, Rabindran S, Palmer GA, Mett V, Yusibov V.

Vaccine. 2007 Apr 20;25(16):3111-4. Epub 2007 Jan 22.

PMID:
17280756
Items per page

Supplemental Content

Write to the Help Desk